GV backs hair loss biotech out of UCLA with PhII set for mid-2024

Pelage Pharmaceuticals, a Los Angeles-based hair loss biotech based on research out of UCLA, has reeled in a $16.75 million Series A and plans to start a mid-stage trial later this year.

GV led the financing, which also included funds from Main Street Advisors, Visionary Ventures…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks